Axon Enterprise (AXON) is back in focus after reporting record quarterly revenue, raising its full-year guidance, and highlighting strong demand for AI tools and counter-drone products across public safety and international customers.
See our latest analysis for Axon Enterprise.
Despite the strong Q1 update and raised guidance, Axon’s recent share price performance has been weak, with the 90 day share price return down 28.9% and the year to date share price return down 30.6%. However, the 5 year total shareholder return of 176.4% still reflects a much stronger long term outcome.
If Axon’s AI and public safety focus has caught your attention, it can be useful to see what else is moving in the sector by scanning 64 profitable AI stocks that aren't just burning cash
So with Axon’s share price lagging recent business results and analysts’ targets sitting well above the current US$391 level, should you view the recent pullback as a potential entry point, or assume the market is already pricing in years of growth?
Most Popular Narrative: 35.5% Undervalued
According to one widely followed narrative, Axon Enterprise’s fair value sits at $606.83, well above the last close at $391.32. This frames the recent pullback in a very different light.
One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.
Curious what kind of growth profile could justify that valuation gap? The narrative leans heavily on recurring software economics, expanding margins and a future earnings multiple that reflects a specialist platform, not just a hardware supplier.
Result: Fair Value of $606.83 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on Axon executing its software shift while managing public sector budgeting cycles and any pushback around AI and public safety use cases.
Find out about the key risks to this Axon Enterprise narrative.
Another View: High Multiple, Higher Expectations
The user narrative leans on future upside, but the current P/S ratio of 10.6x tells a more demanding story. That is richer than both the US Aerospace & Defense industry at 5.3x and direct peers at 7.8x, even though the fair ratio estimate sits higher at 14.3x.
In practice, you are paying a premium that the fair ratio suggests could still be justified, but only if Axon keeps delivering on growth and margins. With that kind of gap, is this an opportunity with room to run, or a setup where expectations leave little margin for error?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If the mixed messages here leave you unsure, that is exactly when it helps to look at the underlying data yourself. Decide quickly where you stand based on 1 key reward and 3 important warning signs.
Looking for more investment ideas?
If Axon has sharpened your interest but you do not want all your money riding on one story, use the screener to compare other clear, data backed opportunities.
- Target potential mispriced opportunities by scanning 46 high quality undervalued stocks that combine quality fundamentals with the possibility of a better entry point.
- Strengthen the core of your portfolio by focusing on companies in the solid balance sheet and fundamentals stocks screener (45 results) that may better handle tough conditions.
- Stay ahead of the crowd by checking the screener containing 22 high quality undiscovered gems before everyone else does.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com